Literature DB >> 8700134

Characterization of hepatic nitric oxide synthase: identification as the cytokine-inducible form primarily regulated by oxidants.

D L Duval1, D R Miller, J Collier, R E Billings.   

Abstract

Induction of hepatic nitric oxide synthase (NOS) by tumor necrosis factor-alpha (TNF alpha), interleukin-1 beta (IL-1 beta), interferon-gamma (IFN gamma), interleukin-6 (IL-6), and lipopolysaccharide was assessed as activity and immunoreactive protein. Hepatic NOS activity was cytosolic and had cofactor requirements consistent with inducible nitric oxide synthase (NOS2). NOS induction by TNF alpha was dose dependent from concentrations of 0.06 to 60 nM and was increased 2-3-fold by IFN gamma. NOS induction was reflective of total TNF alpha binding to hepatocyte receptors. Hepatocyte TNF alpha binding fit a biphasic curve with high affinity (K(d) = 1.4 nM, Bmax = 3157 sites) and low affinity (K(d) = 157 nM, Bmax = 204,948 sites) elements. NOS2 activity was induced by lipopolysaccharide, IL-1 beta, TNF alpha, and IFN gamma but not by IL-6. All cytokine stimuli were inhibited by antioxidants. Oxygen radical generation was directly measured as dichlorofluoroscein fluorescence in isolated mitochondria. Mitochondria from TNF alpha-treated hepatocytes generated more oxygen radicals than did controls. Antioxidants reduced mitochondrial generation of oxygen radicals. Activation of the transcription factor nuclear factor-kappa B by TNF alpha, IFN gamma, and IL-1 beta was assessed by gel shift analysis. Cytokine treatment increased nuclear factor-kappa B binding, and the addition of antioxidants or rotenone inhibited cytokine activation. Taken together, these data suggest that oxygen radicals, possibly generated by mitochondria, play a major role in NOS2 induction by cytokines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8700134

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  5 in total

Review 1.  Oxidative and inflammatory pathways in Parkinson's disease.

Authors:  Rebecca L Miller; Marilyn James-Kracke; Grace Y Sun; Albert Y Sun
Journal:  Neurochem Res       Date:  2008-03-25       Impact factor: 3.996

2.  Inhibition of oxidative stress and cytokine activity by curcumin in amelioration of endotoxin-induced experimental hepatoxicity in rodents.

Authors:  G Kaur; N Tirkey; S Bharrhan; V Chanana; P Rishi; K Chopra
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

3.  An insight into the possible protective effect of pyrrolidine dithiocarbamate against lipopolysaccharide-induced oxidative stress and acute hepatic injury in rats.

Authors:  Hanan H Hagar
Journal:  Saudi Pharm J       Date:  2009-11-10       Impact factor: 4.330

4.  Inhibition of endotoxin-induced hepatotoxicity by melatonin in rats.

Authors:  Praveen Rishi; Sushma Bharrhan; Manmeet Pal Singh Bhalla; Ashwani Koul; Kanwaljit Chopra
Journal:  Int J Biomed Sci       Date:  2008-06

5.  An estrogen receptor dependent mechanism of Oroxylin A in the repression of inflammatory response.

Authors:  Hong Wang; Ying Guo; Xin Zhao; Huiying Li; Guanwei Fan; Haoping Mao; Lin Miao; Xiumei Gao
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.